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Abstract  
 
Introduction: 
One of the most common pathologies in neonates is hyperbilirubinemia, which is a good 
marker for damage to the central nervous system. The sensitivity of the auditory system to 
bilirubin has been previously documented, with much discrepancy in its effects on Auditory 
Brainstem Response results. Thus the objective of this study was to evaluate the effects of 
hyperbilirubinemia on Auditory Brainstem Response of neonates treated with phototherapy. 
 
Materials and Methods:  
Forty-two term neonates with hyperbilirubinemia, who underwent phototherapy participated in 
this cross sectional study. The recording of Auditory Brainstem Response was made shortly after 
confirming that the total serum bilirubin level was greater than 15 µg/dl. Latency of waves I, III, V 
and inter-peak latencies of the waves were measured. To test the hypothesis about the difference 
of means between the two groups, continuous variables were compared using either the t-test 
(normal distribution) or the Mann-Whitney test (non-normal distribution). 
 
Results:   
There was a significant increase in the absolute latencies of waves III and V, and I-III and I-V 
inter-peak latencies of the sample group compared to the control group in both ears (P<0.05). 
However, wave I absolute latency and III-V inter-peak interval did not show a significant 
difference between the two study groups (P>0.05). 
 
Conclusion:   
The results of this study underline the importance of the Auditory Brainstem Response Test as 
an efficient tool for monitoring the auditory brainstem pathway in neonates who are at risk of 
neurotoxicity and for diagnosing the earliest stages of auditory damage caused by high levels of 
bilirubin. 
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Introduction  
One of the most common pathologies in 
neonates is hyperbilirubinemia, which 
clinically manifests as jaundice (1,2). 
Screening of jaundice is suggested in all 
neonates for early detection and treatment of 
hyperbilirubinemia (3). Total serum 
bilirubin (TSB) and neonates’ gestational 
age are the two most important factors in 
evaluating risk factors in these screening 
guidelines, which are that bilirubin's level is 
interpreted according to the neonate’s age in 
hours (4,5).  
Generally, hyperbilirubinemia is a good 
marker for neurologic complaint and 
increase in bilirubin's level is accompanied 
by increased likelihood of damage to the 
central nervous system (CNS) (6). The 
dysfunction induced by hyperbilirubinemia 
includes a wide range of neurological 
damage, dependent on acute or chronic 
exposure of CNS to bilirubin. This spectrum 
includes Kernicterus, acute bilirubin 
encephalopathy, and isolated neural pathway 
dysfunction (7). 
Up to 40 percent of neonates with jaundice 
are at risk of hearing loss (8). The sensitivity 
of the auditory system to bilirubin has been 
previsouly documented and many 
researchers reported the relationship 
between hyperbilirubinemia and damage to 
the auditory system (9-11). Auditory 
brainstem nucleuses and inferior colliculus 
are affected by hyperbilirubinemia (12). 
Additionally abnormalities in spiral ganglion 
neurons and myelinated auditory fibers are 
reported (13). Some studies have shown that 
a baby's auditory system is influenced by 
neonatal jaundice (14-16). 
The damage to the auditory system has 
long-term and permanent effects, since 
language development is completely 
dependent on auditory function (17). 
Auditory Brainstem Response (ABR) is a 
reliable and objective electrophysiological 
method for evaluating ascending auditory 
systems. It relies on recording the electrical 
activity of the auditory system that occurs in 
response to an appropriate acoustic stimulus 
(18).  
A review of literature reveals that most of 
the studies have shown abnormal ABR 
results in infants with hyperbilirubinemia, 
usually with an increase in the wave's 
latency. ABR abnormality in these infants is 
recommended as an indication of bilirubin 
ototoxicity (19-21). On the other hand, 
another category of studies did not find any 
abnormalities in these groups of patients 
(22-24) .Thus the present study aimed at 
evaluating the effects of Hyperbilirubinemia 
on Auditory Brainstem Response of 
neonates treated with phototherapy. 
 
Materials and Methods 
Patients 
This cross-sectional study included forty 
two term neonates (20 boys, 22 girls) who 
were diagnosed with hyperbilirubinemia 
within 10 days after birth. The mean total 
bilirubin ≥15 µg/dl, ranged between 15.4, 
27.6 µg/dl (18.7 ± 3.1 µg/dl). The neonates 
underwent phototherapy in Imam Khomeini 
hospitals of Tehran, between October and 
December 2012. Birth weight in the study 
group ranged between 2700, 4500 g 
(3255.48±449.11 g). 
The exclusion criterion for this study was 
presence of neonatal hypoxia (assessed as 
Apgar value lower than 7 in the fifth 
minute), intrauterine infections, sepsis or 
meningitis and craniofacial malformations, 
a family history of hearing loss, low birth 
weight, ototoxic medication, congenital 
malformations, and altered otoscopy. 
The control group was composed of forty 
term neonates who did not have any major 
perinatal conditions and showed no evidence 
of hyperbilirubinemia. Their birth weight 
ranged between 2800, 4700g (3555± 
350.23g). ABR recordings were made 10 
days after the birth. At the time of the test, 
gestational age ranged between 37 and 40 
weeks (38.75 ± 0.55) in the control group 
and 37, and39 weeks (38.59±0.73 weeks) in 
the study group, which did not have any 
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significant differences. It should be noted 
that although ABR is a completely 
noninvasive technique, written parental 
consent was obtained prior to the study. 
 
ABR testing 
The recording of ABR was made within 
24 hours after confirming that the TSB 
level was greater than 15 µg/dl. Prior to 
ABR recording, the external acoustic canal 
was inspected to prevent any blockage of 
the meatus by wax or collapsing the 
acoustic lumen. Both ears were tested in 
all neonates. The ABR recordings began 
after the neonates had had natural sleep. A 
Charter model Evoked potential system by 
Denmark was used for ABR recordings. 
Three disk electrodes were placed at 
ipsilateral earlobe (negative), contralateral 
earlobe (positive), and middle forehead 
(ground). The interelectrode impedance 
was kept below 5 kΩ during the test. The 
acoustic stimulus was rarefaction clicks of 
100 µs that was presented monaurally to 
TDH 39 earphones. 2000 stimuli of 80 dB 
normal hearing level by repetition rate of 
21.1 /second was averaged in time window  
of 15 ms. 2048 brain responses were 
amplified and filtered by bandpass filer of 
100-3000 Hz. 
 
Data analyses 
Latency of waves I, III, V and inter-peak 
latencies of the waves were measured and 
calculated after averaging the two replicable 
recordings without any knowledge about the 
neonates medical history. In order to test the 
hypothesis about the difference of means 
between the two groups, continuous 
variables were compared using either the t-
test (normal distribution) or the Mann-
Whitney test (non-normal distri bution). 
 
Results  
Comparison of ABR absolute latencies 
(mean±sd) in neonates with hyperbili 
rubinemia and normal controls are shown in 
table 1. As can be seen in the table, there is a  
significant increase in absolute latencies of 
waves III and V in the sample group 
compared to the control group in both ears 
(P<0.05). However, the wave I absolute 
latency does not show significant difference 
between two study groups (P>0.05). 
 
Table1: Measurements of ABR  absolute latencies in neonates with hyperbilirubinemia and normal controls 
ABR variables Ear Group Mean ± sd Statistics P 
 
 
I Latency (ms) 
 
R 
sample 1.35 ± .11 
-1.04 0.29 
Control 1.31 ± .10 
 
L 
sample 1.33 ± .11 
-0.46 0.64 
Control 1.30 ± .09 
 
 
III Latency (ms) 
 
R 
sample 4.23 ± .26 
18.80 <0.0001 
Control 3.40 ± .10 
 
L 
sample 4.23 ± .24 
-7.72 <0.0001 
Control 3.42 ± .23 
 
 
V Latency (ms) 
 
R 
sample 7.90 ± .70 
-7.79 <0.0001 
Control 5.71 ± .23 
 
L 
sample 7.82 ± .65 
-7.76 <0.0001 
Control 5.76 ± .32 
Salehi N, et al 
26   Iranian Journal of Otorhinolaryngology, Vol.28(1), Serial No.84, Jan 2016 
On the other hand, table 2 shows 
comparisons of ABR interpeak latencies in 
neonates with hyperbilirubinemia and 
normal controls. I-III and I-V interpeak 
latencies are significantly longer in the 
sample group compared to the control group 
(P<0.05). There is no significant difference 
in the III-V interpeak interval between the 
two study groups (P>0.05). 
Fig 1 shows the mean of the ABR variable 
in the right ear of both study groups. It is 
obvious that wave V has the most difference 
between these two groups. 
 
 
Table 2: Measurements of ABR inter-peak latencies in neonates with hyperbilirubinemia and normal controls 
ABR variables Ear Group Mean ± sd Statistics P 
 
 
 
 
I-III Inter-peak (ms) 
 
R 
 
sample 
2.92 ± .23 
 
19.44 <0.0001 
Control 2.08 ± .14 
 
L sample 2.94 ± .24 
-7.76 <0.0001 
Control 2.12 ± .25 
 
 
 
 
I-V Inter-peak (ms) 
 
R sample 5.29 ± .36 
13.18 <0.0001 
Control 4.40 ± .23 
 
L 
sample 5.35 ± .33 
-7.46 <0.0001 
Control 4.45 ± .34 
 
 
 
 
III-V Inter-peak (ms) 
 
R sample 2.38 ± .21 
-0.60 0.54 
Control 2.31 ± .27 
 
L 
sample 2.42 ± .21 
-1.36 0.17 
Control 2.33 ± .34 
      
Fig1:     
Lat.I.R: Latency of wave I in Right ear 
Lat.III.R:Latency of wave III in Right ear 
Lat.V.R:Latency of wave V in Right earLat.I-III.R: Interpeak Latency of I-III in Right ear 
Lat.I-V.R:Interpeak Latency of I-V in Right ear 
Lat.III.V.R:Interpeak Latency of III-V in Right ear 
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Discussion  
Significant increase in unconjugated 
bilirubin in neonates, with other peripheral 
risk factors, makes bilirubin cross the 
blood brain barrier and induce acute 
encephalopathy. In neonates with severe 
and long term hyperbilirubinemia, 
deposition of unconjugated and free 
bilirubin in special brain areas causes 
encephalopathy (25,26). In spite of large 
developments in medicine in recent years, 
hyperbili rubinemia and its effects on 
sensory and motor systems is still a major 
problem (27). Early discharge of neonates 
from the hospital, inadequate knowledge 
about severe effects of hyperbilirubinemia, 
and incomplete follow-up programs in 
these high risk group are mentioned as the 
main causes of this big problem in 
previous studies (28,29).  
The neonatal auditory system is very 
sensitive to high levels of bilirubin and can 
be affected in hyperbilirubinemia (30).  
It is well known that neonatal ABRs have 
three waves, I, III and V with latency values 
that have physiological and clinical 
importance, because change in latency 
values is indicative of disturbances in the 
auditory brainstem function (31). 
Wave I originates from spiral ganglion 
cells of the auditory nerve that connect to 
the cochlea. Waves III and V are attributed 
to lower and upper brainstem areas, 
respectively (32).  
In our study, like most of the previous 
studies in this context (33-35), absolute 
latencies of waves III and V are significantly 
longer in neonates with hyperbilirubinemia 
than normal controls. As there was not any 
increase in wave I latency in these neonates, 
the increase in later waves may be due to an 
abnormality in the central auditory pathway. 
This is confirmed by longer I-III and I-V 
interpeak intervals that show brainstem 
conduction time. 
Biochemical and physiological evidences 
introduce the synapses as the primary target 
for bilirubin effects. Synapses along the 
auditory brainstem pathway can be disturbed 
severely (26). This is supported by an 
increase in I-III and I-V interpeak latencies, 
which are found in this study.  
As it is demonstrated in Figure 1, most of 
the increase occurred in wave V absolute 
latency and consequently the increase in I-V 
interpeak latency is greater than a similar 
case in the I-III interpeak latency. This 
finding shows that the rostral regions of the 
brainstem, rather than the caudal ones, are 
more sensitive to an increase in bilirubin 
levels. 
There was not any significant difference in 
wave I absolute latency between both study 
groups in this study. This is in agreement 
with previous studies and can be due to the 
non-involvement of the cochlear nerve 
(16,36). If the hyperbilirubinemia is very 
severe, an increase in wave I absolute 
latency can be observed as well (37,38).  
The results of this study and previous 
studies demonstrate that auditory brainstem 
nucleuses are the main target of bilirubin 
effects in these neonates. Thus using the 
Oto-acoustic Emission (OAE) test alone in 
screening programs for high risk neonates, 
before discharge from the hospital, is 
obviously inadequate (11,38,39). On the 
other hand, these central auditory 
impairments, which are observed in this 
study, can have important clinical 
implications. We did not follow-up the 
neonates after treatment or exchange 
transfusion. But persistence of ABR 
abnormalities in some cases, even  after 
discharge from the hospital (shown in 
previous studies), can indicate axonal 
degeneration and loss of myelin and 
highlight the importance of rapid treatment 
(40). Thus differentiation of peripheral from 
central auditory impairment and special 
attention to central impairments in these 
patients after neonatal hyperbilirubinemia 
has great importance. It must be noted that 
as the neonates in this study did not have 
any pathological process that could have 
affected ABR responses, the observed 
changes in latency values can be mainly 
attributed to an increase in bilirubin levels. 
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Conclusion 
Results of this study underline the 
importance of auditory evoked potentials in 
evaluating the neonatal auditory system. 
ABRs can be an efficient tool for monitoring 
the auditory brainstem pathway in neonates 
who are at risk of neurotoxicity. Diagnosing 
the earliest stages of auditory damage caused 
by high levels of bilirubin is key at a stage 
where lasting central effects may be 
preventable.  
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